YURINEX
Tablet, 1mg
RxActive license
Active substance (INN)
bumetanide
Pharmaceutical form
Pharmaceutical formTablet
Strength1mg
PackagingUkupno 20 tableta u blisteru (2x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C03CA02)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJune 24, 2025
Source: CInMED register